Skip to content
The Nexus
DossierENTITY

Juliette Cubanski

Coverage of Juliette Cubanski in the Nexus archive.

Earliest in view: Jul 1 · 19:11 UTCMost recent: Aug 18 · 10:50 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHAug 18 · 10:50 UTCWDIV CLICKONDETROIT
    Drug prices have declined sharply, and Trump is taking credit. The reason behind the drop is complex

    Recent federal data shows that U.S. prescription drug prices declined 3.1% from a year ago, the steepest drop since 1963. While Donald Trump has taken credit for these drops through “most favored nation” deals, experts suggest other factors are equally significant. These contributors include competition from generic and biosimilar products, as well as policy changes like the Inflation Reduction Act's allowance for Medicare to negotiate drug costs.

  • HEALTHJul 10 · 02:45 UTCCROSSCUT SEATTLE
    Some Medicare beneficiaries get weight loss drug discount

    The use of GLP-1 drugs for weight loss has increased significantly, with 11% of adults currently using them, up from 3% two years ago. Medicare has enabled some patients to access these drugs, potentially driving further adoption.

  • HEALTHJul 1 · 19:11 UTCFOX 32 CHICAGO
    New Medicare program could help cover your weight loss medication | ChicagoLIVE

    A new Medicare program may allow coverage for certain weight loss medications, which are currently excluded under existing law. Juliette Cubanski of KFF discusses the potential impact of this change.